<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05628948</url>
  </required_header>
  <id_info>
    <org_study_id>19-1451</org_study_id>
    <nct_id>NCT05628948</nct_id>
  </id_info>
  <brief_title>Vascular Lab Resource (VLR) Biorepository</brief_title>
  <official_title>Vascular Lab Resource (VLR) Biorepository Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study of biomarkers obtained from prospectively collected subject samples and their&#xD;
      correlation with cardiovascular and metabolic diseases. The purpose of this initiative is to&#xD;
      develop an enduring tool to allow for collaborative research between clinicians at Cleveland&#xD;
      Clinic Main Campus and basic scientists at the Lerner Research Institute. This collaboration&#xD;
      will allow resources to be available to clinical and basic researchers alike. This tool will&#xD;
      enable research of vascular disease in the Vascular Lab and will leverage this valuable asset&#xD;
      to the fullest extent to allow for interdepartmental collaboration.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We are proposing a study of biomarkers obtained from prospectively collected subject samples&#xD;
      and their correlation with cardiovascular and metabolic diseases. The purpose of this&#xD;
      initiative is to develop an enduring tool to allow for collaborative research between&#xD;
      clinicians at Cleveland Clinic Main Campus and basic scientists at the Lerner Research&#xD;
      Institute. This collaboration will allow resources to be available to clinical and basic&#xD;
      researchers alike. This tool will enable research of vascular disease in the Vascular Lab and&#xD;
      will leverage this valuable asset to the fullest extent to allow for interdepartmental&#xD;
      collaboration.&#xD;
&#xD;
      The care of subjects with vascular and metabolic diseases is very fragmentary, and they&#xD;
      remain underserved clinically and under-studied. We will capitalize on the highly&#xD;
      collaborative clinical environment in HVI and other clinical institutes to develop and&#xD;
      constantly utilize a vascular biobank.&#xD;
&#xD;
      This protocol will study blood, urine, and/or stool samples and clinical data from subjects&#xD;
      with cardiovascular and/or metabolic diseases including: peripheral artery disease, carotid&#xD;
      disease, aneurysmal disease, chronic venous disease, thrombosis, lymphedema and lipedema,&#xD;
      non-atherosclerotic arterial stenosis (vasculitis, fibromuscular dysplasia, arterial&#xD;
      dissection and aneurysmal disease, May-Thurner Syndrome etc.), compressive and spastic&#xD;
      disorders (thoracic outlet syndrome, vasospasm). This initiative will allow for the&#xD;
      opportunity to explore pathways of thrombosis, inflammation, gut microbiome, alterations in&#xD;
      cell signaling, lipid metabolism and other metabolic pathways in vascular diseases. Further,&#xD;
      this study will enhance and expand ongoing efforts in the Vascular Lab to collect data for&#xD;
      the purpose of quality control and safety. The specimen sample collection will enable&#xD;
      biochemical and genetic testing on participants once sufficient numbers are attained.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 14, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2031</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2030</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To collect blood, urine, and/or stool samples for biorepository</measure>
    <time_frame>10 years</time_frame>
    <description>To explore pathways of thrombosis, inflammation, gut microbiome, alterations in cell signaling, lipid metabolism and other metabolic pathways in vascular diseases</description>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <condition>Metabolic Disease</condition>
  <condition>Peripheral Artery Disease</condition>
  <condition>Carotid Disease</condition>
  <condition>Aneurysmal Disease</condition>
  <condition>Venous Disease</condition>
  <condition>Thrombosis</condition>
  <condition>Lymphedema</condition>
  <condition>Lipedema</condition>
  <condition>Non-Atherosclerotic Chronic Arterial Occlusive Disease</condition>
  <condition>Vasculitis</condition>
  <condition>Fibromuscular Dysplasia</condition>
  <condition>Arterial Dissection</condition>
  <condition>May-Thurner Syndrome</condition>
  <condition>Thoracic Outlet Syndrome</condition>
  <condition>Vasospasm</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Genetic testing such including messenger RNA sequencing (mRNA-seq), DNA sequencing including&#xD;
      whole exome sequencing and whole genome sequencing, and protein analysis may be performed&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who are with or at risk for cardiovascular or metabolic disease.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. 18 years or older&#xD;
&#xD;
          2. Subjects capable of providing informed consent document&#xD;
&#xD;
          3. Subjects with diagnosed with or at risk for cardiovascular and metabolic diseases&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Known life expectancy of â‰¤ 6 months at the time of enrollment&#xD;
&#xD;
          2. Known current pregnancy&#xD;
&#xD;
          3. Severe Anemia (last documented hemoglobin &lt; 7.0 g/dL)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Scott Cameron, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Scott Cameron, MD, PhD</last_name>
    <phone>216-444-1680</phone>
    <email>cameros3@ccf.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott Cameron, MD, PhD</last_name>
      <phone>216-444-1680</phone>
      <email>cameros3@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Stanley Hazen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sean Lyden, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jerry Bartholomew, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Natalia Fendrikova Mehlay, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Keith McCrae, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rohan Bhandari, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 16, 2022</study_first_submitted>
  <study_first_submitted_qc>November 16, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 29, 2022</study_first_posted>
  <last_update_submitted>November 16, 2022</last_update_submitted>
  <last_update_submitted_qc>November 16, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 29, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>Scott Cameron, MD, PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thoracic Outlet Syndrome</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Vasculitis</mesh_term>
    <mesh_term>Arterial Occlusive Diseases</mesh_term>
    <mesh_term>Fibromuscular Dysplasia</mesh_term>
    <mesh_term>May-Thurner Syndrome</mesh_term>
    <mesh_term>Aneurysm, Dissecting</mesh_term>
    <mesh_term>Lymphedema</mesh_term>
    <mesh_term>Lipedema</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

